Interactive Explainable Deep Learning Model for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI: A
Mingkai Li1, Zhi Zhang2, Zebin Chen3
1From the Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-sen University, No. 600 Tianhe Rd, Guangzhou 510000, China.
Radiology. Imaging Cancer
|May 30, 2025
Summary
An artificial intelligence (AI) model using MRI accurately diagnosed hepatocellular carcinoma (HCC), improving radiologist accuracy in identifying liver lesions. This deep learning tool enhances diagnostic performance for HCC detection.
Area of Science:
- Radiology and Medical Imaging
- Artificial Intelligence in Medicine
- Oncology Diagnostics
Background:
- Hepatocellular carcinoma (HCC) diagnosis relies on advanced imaging techniques.
- Gadoxetic acid-enhanced MRI provides detailed liver lesion characterization.
- Improving diagnostic accuracy and efficiency in HCC detection remains a clinical need.
Purpose of the Study:
- To develop and validate an artificial intelligence (AI) model for HCC diagnosis using MRI.
- To assess the AI model's performance in classifying focal liver lesions (FLLs).
- To evaluate the impact of AI assistance on radiologist diagnostic performance.
Main Methods:
- Retrospective analysis of gadoxetic acid-enhanced MRI scans from patients with FLLs.
- Development of a deep learning-based AI model for lesion classification (HCC vs. non-HCC).
- External validation of the AI model and assessment of its influence on radiologist LI-RADS categorization.
Main Results:
- The AI model achieved high diagnostic performance, with an area under the ROC curve of 0.97 in the external testing set.
- AI model demonstrated superior sensitivity (91.6%) compared to LI-RADS category 5 (74.8%) for HCC diagnosis.
- AI assistance significantly improved radiologist sensitivity and accuracy in classifying LR-5 lesions.
Conclusions:
- The developed AI model accurately diagnoses HCC based on MRI findings.
- AI-assisted reading improves radiologists' diagnostic performance in identifying HCC.
- This AI tool shows potential for enhancing clinical decision-making in liver lesion assessment.


